Nongshim Holdings Co.,Ltd. (KRX:072710)
South Korea · Delayed Price · Currency is KRW 94,500
+2,700 (2.94%)
Last updated: Apr 8, 2026, 2:06 PM KST
Nongshim Holdings Revenue
In the year 2025, Nongshim Holdings had annual revenue of 858.82B KRW with 7.58% growth. Nongshim Holdings had revenue of 227.33B in the quarter ending December 31, 2025, with 32.55% growth.
Revenue
858.82B
Revenue Growth
+7.58%
P/S Ratio
0.50
Revenue / Employee
143.14B
Employees
6
Market Cap
425.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 858.82B | 60.54B | 7.58% |
| Dec 31, 2024 | 798.27B | 28.78B | 3.74% |
| Dec 31, 2023 | 769.50B | 94.92B | 14.07% |
| Dec 31, 2022 | 674.58B | 33.08B | 5.16% |
| Dec 31, 2021 | 641.50B | 57.92B | 9.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daesang Holdings | 5.63T |
| Daesang | 4.40T |
| Sajodaerim | 3.50T |
| EASY HOLDINGS | 3.39T |
| Pulmuone Corporate | 3.38T |
| SPC Samlip | 3.37T |
| Samyang | 2.56T |
| Kwang Dong Pharmaceutical | 1.66T |